PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Simpson, E.
Lacour, J.
Beck, L.
Zhang, H.
Aamodt, K.
Rossi, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P196
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [41] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [42] Long-term dupilumab treatment up to 100 weeks reduces serum biomarkers in adult patients with moderate-to-severe atopic dermatitis
    Thaci, D.
    Bissonnette, R.
    Deleuran, M.
    Harel, S.
    Chen, Z.
    Levit, N. A.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E122 - E122
  • [43] Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis
    Bakker, Daphne S.
    van der Wal, Maria M.
    Heeb, Lukas E. M.
    Giovannone, Barbara
    Asamoah, Mindy
    Delemarre, Eveline M.
    Drylewicz, Julia
    Nierkens, Stefan
    Boyman, Onur
    de Bruin-Weller, Marjolein S.
    Thijs, Judith L.
    van Wijk, Femke
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (08) : 1943 - +
  • [44] Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    Costanzo, Antonio
    Foley, Peter
    Ardeleanu, Marius
    Wu, Jiangming
    Ozturk, Zafer E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [45] PHARMACOKINETICS OF DUPILUMAB IN LONG-TERM PHASE III STUDIES IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS.
    Davis, J. D.
    Rawal, S.
    Kamal, M.
    Li, M.
    Lai, C. -H.
    Ardeleanu, M.
    DiCioccio, A. T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S61 - S61
  • [46] Laboratory safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Results from an open-label extension (OLE) study
    Blauvelt, Andrew
    Wollenberg, Andreas
    Beck, Lisa A.
    Chen, Zhen
    Zhang, Meng
    Khokhar, Faisal A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB142 - AB142
  • [47] Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
    Ameen, Mahreen
    Alhusaye, Raed
    Brandi, Henrik
    Bogelund, Mette
    Jensen, Henrik H.
    Reitzel, Signe B.
    Thyssen, Jacob P.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [48] Laboratory safety of long-term dupilumab treatment in a 5-year open-label extension study of adults with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Bissonnette, R.
    Deleuran, M.
    Nakahara, T.
    Galus, R.
    Khokhar, F. A.
    Coleman, A.
    Gherardi, G.
    Chen, Z.
    Avetisova, E.
    Dubost-Brama, A.
    Shabbir, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
  • [49] Infections in adults with moderate-to-severe atopic dermatitis treated with dupilumab: long-term data from an open-label extension study
    Blauvelt, A.
    Wollenberg, A.
    Eichenfield, L.
    Chen, Z.
    Sierka, D.
    Vakil, J.
    Khokhar, F. A.
    Cyr, S. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E121 - E121
  • [50] Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race
    Alexis, A. F.
    Silverberg, J. I.
    Rice, Z. P.
    Armstrong, A. W.
    Desai, S. R.
    Fonacier, L.
    Kabashima, K.
    Levenberg, M.
    Biswas, P.
    Cella, R. Rojo
    Chan, G. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E137 - E138
12345